Literature DB >> 24342757

Prevalence of and risk factors of renal artery stenosis in patients with resistant hypertension.

Mina M Benjamin1, Poorya Fazel2, Giovanni Filardo3, James W Choi2, Robert C Stoler4.   

Abstract

Renal artery stenosis (RAS) is a common cause of secondary hypertension. Renal artery angiography is the gold standard for diagnosing RAS. The aim of this study is to report (1) the prevalence of RAS in patients with resistant hypertension and (2) the association of RAS with peripheral vascular disease (PVD) and diabetes mellitus (DM). We studied 285 consecutive patients (mean age: 72.5 years) with resistant hypertension (systolic blood pressure >140 mm Hg despite administration of at least 3 antihypertensive drugs) who underwent renal artery angiography at Baylor Heart and Vascular Hospital from January 2006 to December 2010. Sixty-nine cases of RAS were identified (incidence: 24.2%). The propensity-adjusted analysis (controlling for clinical and nonclinical risk factors) showed a strong and significant association between RAS and PVD (odds ratio 5.15, 95% confidence interval 2.68 to 9.89, p <0.0001). However, the association between RAS and DM, a previously defined risk factor for RAS, was not significant in this cohort (odds ratio 0.63, 95% confidence interval 0.34 to 1.19, p = 0.16). In conclusion, results from this study define the prevalence of RAS in patients with resistant hypertension. Patients with PVD were found to be 5 times more likely to experience RAS than patients without PVD, whereas DM did not confer any increased risk.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 24342757     DOI: 10.1016/j.amjcard.2013.10.046

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  10 in total

Review 1.  Renal Artery Stenosis in Patients with Resistant Hypertension: Stent It or Not?

Authors:  Patricia Van der Niepen; Patrick Rossignol; Jean-Philippe Lengelé; Elena Berra; Pantelis Sarafidis; Alexandre Persu
Journal:  Curr Hypertens Rep       Date:  2017-01       Impact factor: 5.369

2.  Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association.

Authors:  Robert M Carey; David A Calhoun; George L Bakris; Robert D Brook; Stacie L Daugherty; Cheryl R Dennison-Himmelfarb; Brent M Egan; John M Flack; Samuel S Gidding; Eric Judd; Daniel T Lackland; Cheryl L Laffer; Christopher Newton-Cheh; Steven M Smith; Sandra J Taler; Stephen C Textor; Tanya N Turan; William B White
Journal:  Hypertension       Date:  2018-11       Impact factor: 10.190

Review 3.  Resistant Hypertension Updated Guidelines.

Authors:  Irene Chernova; Namrata Krishnan
Journal:  Curr Cardiol Rep       Date:  2019-08-30       Impact factor: 2.931

4.  Comprehensive First-Line Magnetic Resonance Imaging in Hypertension: Experience From a Single-Center Tertiary Referral Clinic.

Authors:  Amy E Burchell; Jonathan C L Rodrigues; Max Charalambos; Laura E K Ratcliffe; Emma C Hart; Julian F R Paton; Andreas Baumbach; Nathan E Manghat; Angus K Nightingale
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-10-19       Impact factor: 3.738

5.  Angiotensin II augments renal vascular smooth muscle soluble GC expression via an AT1 receptor-forkhead box subclass O transcription factor signalling axis.

Authors:  Joseph C Galley; Scott A Hahn; Megan P Miller; Brittany G Durgin; Edwin K Jackson; Sean D Stocker; Adam C Straub
Journal:  Br J Pharmacol       Date:  2021-06-09       Impact factor: 9.473

Review 6.  Functional Assessment of Intermediate Vascular Disease.

Authors:  Teodora Yaneva-Sirakova; Ivanichka Serbezova; Dobrin Vassilev
Journal:  Biomed Res Int       Date:  2018-04-15       Impact factor: 3.411

7.  Excessive dietary salt promotes aortic stiffness in murine renovascular hypertension.

Authors:  Leon J DeLalio; Scott Hahn; Pedro L Katayama; Megan M Wenner; William B Farquhar; Adam C Straub; Sean D Stocker
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-04-17       Impact factor: 4.733

8.  Effects of renal denervation on kidney function and long-term outcomes: 3-year follow-up from the Global SYMPLICITY Registry.

Authors:  Felix Mahfoud; Michael Böhm; Roland Schmieder; Krzysztof Narkiewicz; Sebastian Ewen; Luis Ruilope; Markus Schlaich; Bryan Williams; Martin Fahy; Giuseppe Mancia
Journal:  Eur Heart J       Date:  2019-11-01       Impact factor: 29.983

9.  Cardiovascular Disease Prevention in Patients With Atherosclerotic Renovascular Disease-Induced Resistant Hypertension: Further Considerations for 24-Hour Blood Pressure Profiles.

Authors:  Keisuke Narita; Satoshi Hoshide; Kazuomi Kario
Journal:  J Am Heart Assoc       Date:  2022-08-17       Impact factor: 6.106

Review 10.  Mineralocorticoid Receptor Antagonists Therapy in Resistant Hypertension: Time to Implement Guidelines!

Authors:  Giuseppe Maiolino; Matteo Azzolini; Gian Paolo Rossi
Journal:  Front Cardiovasc Med       Date:  2015-02-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.